Abstract:Background: This study aims to explore the variations of hepatic vascular geometries in patients with clinically significant portal hypertension (CSPH) and investigate the capability of using CT/MRI angiographic imaging-based vascular geometrical model (VGM) to identify CSPH patients. Methods: A total of 64 vascular geometrical parameters were extracted from the portal vein (PV), hepatic vein (HV), aorta and inferior vena cava and then fed into a VGM for identification of CSPH patients. A total of 853 consecutive liver cirrhosis patients from 3 medical centers who underwent contrast-enhanced imaging within 14 days of transjugular catheterization for hepatic venous pressure gradient (HVPG) were included. The VGM model was trained and validated on a CT cohort containing 256 cirrhosis patients and 202 age-matched participants without a history of chronic liver diseases, and tested on both CT and MR cohorts. Findings: Significant reduction of whole vessel volumes were observed in both PV (from 36·90±15·99 to 29·61±11·07 cm3) and HV (from 35·28±21·47 to 22·44±15·65 cm3) when CSPH occurred. Similarly, whole vessel lengths were reduced in CSPH patients in both PV (from 3·00±2·37 to 1·72±1·23 m) and HV (from 1·83±1·48 to 0·91±1·51 m). The number of external associations of vessel parameters (defined as R>0·5) increased when CSPH occurred, which verified the derangement of the vascular system in the liver. The performance of VGM outperformed conventional clinical models significantly in both internal and external validation cohorts. Interpretation: This study developed and validated a contrast-enhanced CT/MRI-based VGM with good diagnostic consistency to the HVPG measurement, which shows good potential for clinical applications.Trial Registration: We conducted this study using the database of a CT cohort (CHESS1701; ClinicalTrials.gov identifier: NCT03138915) between August 2016 and September 2017 and a MR cohort (CHESS1802; ClinicalTrials.gov identifier: NCT03766880) from December 2018 toApril 2019.Funding: This study was funded by the National Natural Science Foundation of China (No. 81971583, No. 62001120), National Key R&D Program of China (No. 2018YFC1312900, No. 2019YFA0709502), Science Fund for Distinguished Young Scholars (No. 20JR10RA713), Shanghai Natural Science Foundation (No. 20ZR1406400), Shanghai Municipal Science and Technology Major Project (No.2017SHZDZX01, No.2018SHZDZX01), Shanghai Municipal Science and Technology (No.17411953600), Shanghai Sailing Program (No. 20YF1402400), ZJLab and Key Laboratory of Computational Neuroscience and BrainInspired Intelligence (Fudan University), Ministry of Education, China.Declaration of Interest: The authors declare no conflict of interest.Ethical Approval: The study was in agreement with the ethical guidelines of the 1975 Declaration ofHelsinki and approved by the Ethics Committee of the Fifth Medical Center at PLAGeneral Hospital. The requirement for informed consent was waived.

A new computational fluid dynamics based noninvasive assessment of portacaval pressure gradient

Application of portal vein pressure measurement based on computational fluid dynamics in preoperative planning of resection of hepatic carcinoma

Computational Fluid Dynamics-Based Blood Flow Assessment Facilitates Optimal Management of Portal Vein Stenosis After Liver Transplantation

Non-invasive Assessment of Hepatic Venous Pressure Gradient (HVPG) Based on MR Flow Imaging and Computational Fluid Dynamics

Computed tomography perfusion in differentiating portal hypertension: A correlation study with hepatic venous pressure gradient

Four-dimensional Flow MRI-based Computational Fluid Dynamics Simulation for Noninvasive Portosystemic Pressure Gradient Assessment in Patients with Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt

Status of transjugular intrahepatic portosystemic shunt for portal hypertension in China:A national survey analysis

Status of transjugular intrahepatic portosystemic shunt for portal hypertension in China: A national survey analysis

Noninvasive Assessment of Portal Hypertension by Ultrasonography

Application of 64-Slice Spiral CT on the Measurement of Puncture Channel of Simulated Direct Intrahepatic Portacaval Shunt

Flow Resistance Analysis of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis.

Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model

Do the stent blind insertion into the main portal vein (MPV) and stent diameter influence the surgical outcome of the transjugular intrahepatic portosystemic shunt (TIPS)?

Double C-Arm Digital Subtraction Angiography Guidance During Transjugular Intrahepatic Portosystemic Shunt Placement

Intrahepatic arterial localizer guided transjugular intrahepatic portosystemic shunt placement: Feasibility, efficacy, and technical success assessed by a case series-a STROBE- compliant article.

Non-invasive predictive model for hepatic venous pressure gradient based on a 3-dimensional computed tomography volume rendering technology

Development and Validation of a Hepatic Vascular Geometrical Model for Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)

Preliminary clinical observation of double C-arm digital subtraction angiography guidance during transjugular intrahepatic portosystemic shunt placement

Analyses on Clinical Efficacy of TIPS in the Treatment of Cirrhotic Portal Hypertension and Relevant Influencing Factors

CBCT-based Three-Dimensional Dual-Phase Vascular Image Fusion: a Novel Technique for Interventional Real-Time TIPS Guidance

Four-dimensional Flow Magnetic Resonance Imaging for Noninvasive Diagnosis of Clinically Significant Portal Hypertension and High-Risk Gastroesophageal Varices in Patients with Cirrhosis